Drug Week
Susan Hasty, Publisher
Table of Contents . . . December 14th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
AIDS and HIV Therapy - Dexamethasone Can Reduce CD4 Cell Loss
Mycobacteria - S28463 Effectively Treats Mycobacterium bovis Infection
Arthritis - FDA Approves New Class Of Therapy For Rheumatoid Arthritis
COX-2 Inhibitors - Celecoxib Does Not Increase Risk Of Cardiovascular Adverse Events
COX-2 Inhibitors - Valdecoxib Effective In Treating OA And RA With Fewer Gastrointestinal Side Effects
Myocardial Infarction - Prehospital Administration of Reteplase Saves Time To Treatment
Osteoporosis - Risedronate Sodium Once A Week As Effective As Daily Dose
Tuberculosis Therapy - Moxifloxacin May Make Effective Isoniazid Supplement
Acute Coronary Syndrome - Promising Results From Fondaparinux Trial Reported
Alzheimer Disease - Cell Model Of Oxidative Stress Valuable For Screening Drugs
Angina - Phase III CARISA Trial Meets Primary Endpoint
Dermatology - Schering AG Acquires Worldwide Rights For Dermatitis Drug
Drug Delivery - New Transmucosal Technology Being Evaluated
Drug Delivery - Quintiles And Capsugel Expand Alliance for Capsule Capabilities
Drug Development - MAXIA Presents Data On Novel Small Molecule Anticancer Agents
Drug Development - NEO-339 Improves Attentional Deficits, Learning, And Memory In Animals
Drug Development - Novel Drug Candidates Address Cognitive Deficits Of Psychotic Patients
Drug Development - Valsartan Reduces Total Heart Failure Hospitalizations
Drug Toxicities - Sleuthing, A Required Skill For Rheumatologists
Erectile Dysfunction - Two Phase III Clinical Trials Of Topical Drug Initiated Concurrently
Finance - United Therapeutics Shows Continued Growth In Revenues In Third Quarter
Head And Neck Cancer - IntraDose Receives Nonapprovable Letter From FDA
Heart Failure - Hormonal Study Shows Valsartan Significantly Reduces Severity Marker
Myocardial Infarction - Intravenous Amiodarone Demonstrated To Be More Effective Than Lidocaine
Nail Fungus - EcoNail Technology Holds Potential For Revolutionizing Treatment
Osteoarthritis - Celecoxib Associated With Reduced Hospitalizations And Office Visits
Osteoarthritis - Second Study Confirms Celecoxib Is Comparable With Rofecoxib
Psychosis - Acadia Nominates 5-HT2A Inverse Agonist For Clinical Development
Research - FDA Purchases LeadScope Enterprise And ToxScope Toxicity Databases
Research - InnaPhase Signs Agreement With Pfizer For Drug Metabolism, Pharmacokinetic Data
Rheumatoid Arthritis - IKK-2 Inhibitor Blocks Disease Progression In Preclinical Model
Schizophrenia - New Drug Application Submitted For Aripiprazole
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
